摘要
简介:以磁共振成像(MRI)为基础的分割广泛用于临床上脑的研究,特别是与正电子发射断层扫描(PET)结合。虽然人工由于分割引起的错误很普遍,但是这些人为对正电子发射断层扫描定量影响尚未被系统地研究。因此,本研究的目的是评估分割错误在[18F]-AV45 and [18F]- 氟脱氧葡萄糖正电子发射断层扫描和定量的影响,伴不伴随部分容积效应(PVE)校正。材料和方法:119名受试者同时[18F]-AV45,[18F] -氟脱氧葡萄糖正电子发射断层扫描,以及在基线T1加权磁共振成像和后续两年是来自阿尔茨海默氏病影像学倡议的队列中,他们的使用PMOD 3.5分割脑部磁共振成像图像。人工分割核磁共振屏蔽相应的[18F]- 氟脱氧葡萄糖正电子发射断层扫描标准摄取值(SUV)形象来阐明六大成交量体积(VOI)定量分析影响人控正电子发射断层扫描。计算每个成交量体积,连同错误-[ % ]和未修正的均方根误差(RMSE)和部分容积效应校正标准摄取值的结果为两个正电子发射断层扫描示踪剂。我们还评估了纵向正电子发射断层扫描数据的偏差。结果:人为最经常发生在顶叶皮质区成交量体积。对于[18F]-AV45,[18F] -氟脱氧葡萄糖正电子发射断层扫描,百分比误差取决于工作成交量指标。因此,视频差错隐消准摄取值比未修正的相对物更加扭曲。在静态和纵向评价,一小部分人的大型工件(≥1500像素;5.06厘米³)占了多大的正电子发射断层扫描定量偏差。结论:大分割工件需要检测和他们相当的偏见正电子发射断层扫描定量解决,尤其是在肺血管内皮细胞应用于正电子发射断层扫描数据。
关键词: 淀粉正电子发射断层扫描,人工产品,氟脱氧葡萄糖正电子发射断层扫描,掩蔽,核磁共振成像,部分容积效应校正,分割。
Current Alzheimer Research
Title:Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation
Volume: 13 Issue: 5
Author(s): Marcus Högenauer, Matthias Brendel, Andreas Delker, Sonja Därr, Mayo Weiss, Peter Bartenstein, Axel Rominger and Alzheimer’s Disease Neuroimaging Initiative
Affiliation:
关键词: 淀粉正电子发射断层扫描,人工产品,氟脱氧葡萄糖正电子发射断层扫描,掩蔽,核磁共振成像,部分容积效应校正,分割。
摘要: Introduction: Magnet resonance image (MRI)-based segmentations are widely used for clinical brain research, especially in conjunction with positron-emission-tomography (PET). Although artifacts due to segmentation errors arise commonly, the impact of these artifacts on PET quantitation has not yet been investigated systematically. Therefore, the aim of this study was to assess the effect of segmentation errors on [18F]-AV45 and [18F]-FDG PET quantitation, with and without correction for partial volume effects (PVE). Material and Methods: 119 subjects with both [18F]-AV45, and [18F]-FDG PET as well as T1-weighted MRI at baseline and at two-year follow-up were selected from the ADNI cohort, and their MRI brain images were segmented using PMOD 3.5. MRIs with segmentation artifacts were masked with the corresponding [18F]-FDG PET standard-uptake-value (SUV) images to elucidate and quantify the impact of artifacts on PET analyses for six defined volumes-of-interest (VOI). Artifact volumes were calculated for each VOI, together with error-[%] and root-mean-square-errors (RMSE) in uncorrected and PVE corrected SUV results for the two PET tracers. We also assessed the bias in longitudinal PET data. Results: Artifacts occurred most frequently in the parietal cortex VOI. For [18F]-AV45 and [18F]-FDG PET, the percentage-errors were dependent on artifact volumes. PVEC SUVs were consequently more distorted than were their uncorrected counterparts. In static and longitudinal assessment, a small subgroup of subjects with large artifacts (≥1500 voxels; ≙5.06 cm³) accounted for much of the PET quantitation bias. Conclusion: Large segmentation artifacts need to be detected and resolved as they considerably bias PET quantitation, especially when PVEC is applied to PET data.
Export Options
About this article
Cite this article as:
Marcus Högenauer, Matthias Brendel, Andreas Delker, Sonja Därr, Mayo Weiss, Peter Bartenstein, Axel Rominger and Alzheimer’s Disease Neuroimaging Initiative , Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation, Current Alzheimer Research 2016; 13 (5) . https://dx.doi.org/10.2174/156720501304160325175855
DOI https://dx.doi.org/10.2174/156720501304160325175855 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Structure Based Virtual Screening for the Identification of Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of <i>Streptococcus pneumoniae</i>
Current Bioinformatics Utilising Nanotechnology and Nanosystems for Treatment of Rare Diseases
Pharmaceutical Nanotechnology Heat Shock Proteins And Neuroprotection
Recent Patents on DNA & Gene Sequences Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
Current Medicinal Chemistry Carbohydrate based Potential Chemotherapeutic Agents: Recent Developments and their Scope in Future Drug Discovery
Mini-Reviews in Medicinal Chemistry Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
Current Neuropharmacology Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine Combined Therapies for Lysosomal Storage Diseases
Current Molecular Medicine Tuberculous Pericarditis
Current Cardiology Reviews Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Antifungal Proteins: Potent Candidate for Inhibition of Pathogenic Fungi
Current Bioactive Compounds Editorial [Hot topic: Melatonin and Brain (Guest Editor: Dun-Xian Tan)]
Current Neuropharmacology Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods
Current Medicinal Chemistry Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Synthesis and Antibacterial Activity of New Chalcones Bearing an Imidazo[ 1,2-a]pyridine Moiety
Current Chemical Biology Cisternal Sustained Release Dihydropyridines for Subarachnoid Hemorrhage
Current Neurovascular Research The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies
Medicinal Chemistry Advancement in Nanoparticle-based Biosensors for Point-of-care <i>In vitro</i> Diagnostics
Current Topics in Medicinal Chemistry